Evidence map›Paper›PMID 29193309›Full record

ReviewJournal of neuroscience research2019

Converging early responses to brain injury pave the road to epileptogenesis.

Eric J Neuberger, Akshay Gupta, Deepak Subramanian, Akshata A Korgaonkar, Vijayalakshmi Santhakumar

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroscience research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. In Focus: Disease promoters during epileptogenesis.Journal of neuroscience research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eric J NeubergerDepartment of Pharmacology, Physiology & Neuroscience, Rutgers New Jersey Medical School, Newark, NJ.
Akshay GuptaDepartment of Pharmacology, Physiology & Neuroscience, Rutgers New Jersey Medical School, Newark, NJ.
Deepak SubramanianDepartment of Pharmacology, Physiology & Neuroscience, Rutgers New Jersey Medical School, Newark, NJ.
Akshata A KorgaonkarDepartment of Pharmacology, Physiology & Neuroscience, Rutgers New Jersey Medical School, Newark, NJ.
Vijayalakshmi SanthakumarDepartment of Pharmacology, Physiology & Neuroscience, Rutgers New Jersey Medical School, Newark, NJ.ORCID 0000-0001-6278-4187
Rutgers, The State University of New Jersey · US

Funding

Contribution of Innate Immune Receptors to Neurological Dysfunction After Traumatic Brain Injury: Mechanisms and Therapeutic ImplicationsR01NS097750 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI SANTHAKUMAR, VIJAYALAKSHMI · 2016 to 2025
$4.0M
Perisomatic Inhibitory Network Dysfunction in Neurological DiseaseR01NS069861 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SANTHAKUMAR, VIJAYALAKSHMI · 2011 to 2022
$3.4M
NINDS NIH HHS R01 NS069861NINDS NIH HHS R01 NS097750
6 · The paper itself

Abstract

Epilepsy, characterized by recurrent seizures and abnormal electrical activity in the brain, is one of the most prevalent brain disorders. Over two million people in the United States have been diagnosed with epilepsy and 3% of the general population will be diagnosed with it at some point in their lives. While most developmental epilepsies occur due to genetic predisposition, a class of "acquired" epilepsies results from a variety of brain insults. A leading etiological factor for epilepsy that is currently on the rise is traumatic brain injury (TBI), which accounts for up to 20% of all symptomatic epilepsies. Remarkably, the presence of an identified early insult that constitutes a risk for development of epilepsy provides a therapeutic window in which the pathological processes associated with brain injury can be manipulated to limit the subsequent development of recurrent seizure activity and epilepsy. Recent studies have revealed diverse pathologies, including enhanced excitability, activated immune signaling, cell death, and enhanced neurogenesis within a week after injury, suggesting a period of heightened adaptive and maladaptive plasticity. An integrated understanding of these processes and their cellular and molecular underpinnings could lead to novel targets to arrest epileptogenesis after trauma. This review attempts to highlight and relate the diverse early changes after trauma and their role in development of epilepsy and suggests potential strategies to limit neurological complications in the injured brain.

Indexed as

AnimalsBrainBrain Injuries, TraumaticEpilepsyHumansNeurogenesisNeuronsSignal Transductiondentate gyrusexcitotoxicityneurogenesisneuroinflammationtraumatic brain injury

Identifiers

PMID29193309
PMCPMC5975115
OpenAlexW2770735186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.